Cargando…

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches

The D-amino acid oxidase activator (DAOA, also known as G72) gene is a strong schizophrenia susceptibility gene. Higher G72 protein levels have been implicated in patients with schizophrenia. The current study aimed to differentiate patients with schizophrenia from healthy individuals using G72 sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Eugene, Lin, Chieh-Hsin, Lai, Yi-Lun, Huang, Chiung-Hsien, Huang, Yu-Jhen, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232512/ https://www.ncbi.nlm.nih.gov/pubmed/30459659 http://dx.doi.org/10.3389/fpsyt.2018.00566

Ejemplares similares

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia
por: Chang, Jane Pei-Chen, et al.
Publicado: (2020)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

PICK1 Genetic Variation and Cognitive Function in Patients with Schizophrenia
por: Chen, Yi-Ting, et al.
Publicado: (2017)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

The C-Terminal Region of G72 Increases d-Amino Acid Oxidase Activity
por: Chang, Sunny Li-Yun, et al.
Publicado: (2013)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia
por: Bass, Nicholas J, et al.
Publicado: (2009)

Investigation of G72 (DAOA) expression in the human brain
por: Benzel, Isabel, et al.
Publicado: (2008)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Adaptive evolution and elucidating the potential inhibitor against schizophrenia to target DAOA (G72) isoforms
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2015)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment
por: Pósfai, B, et al.
Publicado: (2016)

Expression of the G72/G30 gene in transgenic mice induces behavioral changes
por: Cheng, Lijun, et al.
Publicado: (2013)

Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients
por: Lin, Chieh-Hsin, et al.
Publicado: (2023)

Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms
por: Sehgal, Sheikh Arslan
Publicado: (2017)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
por: Huang, Yu-Jhen, et al.
Publicado: (2017)

beta-decay properties of Ni72 and Cu72
por: Thomas, J C, et al.
Publicado: (2006)

DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis
por: Mössner, Rainald, et al.
Publicado: (2009)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

PM539. Evaluation of plasma and cerebrospinal fluid G72 protein levels and their correlations with psychiatric symptoms in schizophrenia and major depression
por: Ishiwata-Matsushima, Sayuri, et al.
Publicado: (2016)

Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia
por: Rowland, Laura M., et al.
Publicado: (2017)

Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects
por: Jansen, Andreas, et al.
Publicado: (2009)

Multi-Omics Analysis Reveals Myelin, Presynaptic and Nicotinate Alterations in the Hippocampus of G72/G30 Transgenic Mice
por: Filiou, Michaela D., et al.
Publicado: (2022)

Lack of C9orf72 Repeat Expansion in Taiwanese Patients with Mixed Neurodegenerative Disorders
por: Lin, Chin-Hsien, et al.
Publicado: (2014)

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease
por: Huang, Yu-Jhen, et al.
Publicado: (2012)

Hacking Vim 72
por: Schulz, Kim
Publicado: (2010)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

The effects of Baduanjin exercise vs. brisk walking on physical fitness and cognition in middle-aged patients with schizophrenia: A randomized controlled trial
por: Chen, Chyi-Rong, et al.
Publicado: (2022)

The effects of molecular crowding and CpG hypermethylation on DNA G-quadruplexes formed by the C9orf72 nucleotide repeat expansion
por: Ozcan, Kadir. A., et al.
Publicado: (2021)

G-Quadruplexes Formation by the C9orf72 Nucleotide Repeat Expansion d(GGGGCC)(n) and Conformation Regulation by Fangchinoline
por: Zhang, Yun, et al.
Publicado: (2023)

Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
por: Schludi, Martin H, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lus0a09h15oko6mblfjc8n9sru